Mendaera rolls out handheld needle robot paired with Butterfly ultrasound probe. Mendaera announced its handheld robot for needle-based procedures is now available to pair with Butterfly Network's (NYSE:BFLY) portable, chip-based ultrasound probe, following the companies' long-running collaboration. The Focalist robotic image-guided system assists clinicians in aiming to place IV lines, deliver nerve blocks or otherwise access organs and vasculature without additional specialized training. After FDA clearance in July 2025, its first procedures included removing kidney stones through minimally invasive nephrolithotomy. Mendaera signed up as the first partner in the Butterfly Embedded technology licensing program, shortly after the developer's debut in 2023, with a commercialization deal that included sharing the revenue of every combined unit sold.

Mendaera has launched a version of its Focalist system compatible with Butterfly Network's Ultrasound-on-Chip technology. This marks the first Butterfly Embedded partner technology to reach the market. Mendaera's FDA-cleared Focalist system combines handheld robotics, real-time imaging, and intelligent guidance software for image-guided needle procedures, including vascular access, regional nerve blocks, and organ access. The collaboration brings together imaging and robotics technologies with the aim of advancing digitally native, AI-enabled intervention. Butterfly's software-defined architecture enables a path towards AI-enabled image interpretation and robotic action. Mendaera and Butterfly will both exhibit at the American College of Emergency Physicians Scientific Assembly on 5-7 October 2026 in Chicago, Illinois.